Latest period
2.45B
YoY change
0.0%
5Y CAGR
-1.9%
Peak year (2003)
3.14B
Latest annual
2.43B
Shares Outstanding history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: 2.43B
Shares Outstanding growth chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: 0.0%
Shares Outstanding history table for Johnson & Johnson (JNJ) from 1985 to 2025
| 2025 | 2.43B | 0.0% | 0 | ||
| 2024 | 2.43B | -5.1% | -131.00M | ||
| 2023 | 2.56B | -3.9% | -103.50M | ||
| 2022 | 2.66B | -0.4% | -10.10M | ||
| 2021 | 2.67B | +0.1% | +3.30M | ||
| 2020 | 2.67B | -0.5% | -13.60M | ||
| 2019 | 2.68B | -1.6% | -44.40M | ||
| 2018 | 2.73B | -0.6% | -16.60M | ||
| 2017 | 2.75B | -1.6% | -43.60M | ||
| 2016 | 2.79B | -0.9% | -24.00M | ||
| 2015 | 2.81B | -1.8% | -51.00M | ||
| 2014 | 2.86B | -0.5% | -13.10M | ||
| 2013 | 2.88B | +2.3% | +64.40M | ||
| 2012 | 2.81B | +1.3% | +37.30M | ||
| 2011 | 2.78B | -0.5% | -13.50M | ||
| 2010 | 2.79B | -0.0% | -300,000 | ||
| 2009 | 2.79B | -1.6% | -46.50M | ||
| 2008 | 2.84B | -2.6% | -75.10M | ||
| 2007 | 2.91B | -1.8% | -52.57M | ||
| 2006 | 2.96B | -1.3% | -39.71M | ||
| 2005 | 3.00B | +0.6% | +17.58M | ||
| 2004 | 2.99B | -5.0% | -157.39M | ||
| 2003 | 3.14B | +2.9% | +88.63M | ||
| 2002 | 3.05B | -0.9% | -26.27M | ||
| 2001 | 3.08B | -0.6% | -18.77M | ||
| 2000 | 3.10B | +0.8% | +25.10M | ||
| 1999 | 3.07B | +8.5% | +241.08M | ||
| 1998 | 2.83B | +3.4% | +91.94M | ||
| 1997 | 2.74B | +0.5% | +14.76M | ||
| 1996 | 2.73B | +5.5% | +142.32M | ||
| 1995 | 2.58B | -0.8% | -22.00M | ||
| 1994 | 2.61B | -0.8% | -21.94M | ||
| 1993 | 2.63B | +0.0% | +757,176 | ||
| 1992 | 2.63B | -2.9% | -78.37M | ||
| 1991 | 2.71B | +0.6% | +16.14M | ||
| 1990 | 2.69B | -0.6% | -15.59M | ||
| 1989 | 2.71B | -2.8% | -77.86M | ||
| 1988 | 2.78B | +1.9% | +51.71M | ||
| 1987 | 2.73B | -0.5% | -14.69M | ||
| 1986 | 2.75B | -6.0% | -176.55M | ||
| 1985 | 2.92B | — | — |
- 20252.43B0.0%
- 20242.43B-5.1%
- 20232.56B-3.9%
- 20222.66B-0.4%
- 20212.67B+0.1%
- 20202.67B-0.5%
- 20192.68B-1.6%
- 20182.73B-0.6%
- 20172.75B-1.6%
- 20162.79B-0.9%
- 20152.81B-1.8%
- 20142.86B-0.5%
- 20132.88B+2.3%
- 20122.81B+1.3%
- 20112.78B-0.5%
- 20102.79B-0.0%
- 20092.79B-1.6%
- 20082.84B-2.6%
- 20072.91B-1.8%
- 20062.96B-1.3%
- 20053.00B+0.6%
- 20042.99B-5.0%
- 20033.14B+2.9%
- 20023.05B-0.9%
- 20013.08B-0.6%
- 20003.10B+0.8%
- 19993.07B+8.5%
- 19982.83B+3.4%
- 19972.74B+0.5%
- 19962.73B+5.5%
- 19952.58B-0.8%
- 19942.61B-0.8%
- 19932.63B+0.0%
- 19922.63B-2.9%
- 19912.71B+0.6%
- 19902.69B-0.6%
- 19892.71B-2.8%
- 19882.78B+1.9%
- 19872.73B-0.5%
- 19862.75B-6.0%
- 19852.92B—
Shares Outstanding values are taken from Johnson & Johnson's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's latest reported diluted shares outstanding is 2.45B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual diluted shares outstanding for Johnson & Johnson (JNJ) came in at 2.43B – edged up 0.0% year-over-year.
Johnson & Johnson diluted shares outstanding compound annual growth for the 2020–2025 (5 years) window is -1.9%, with a net decline across the window.
Between 2003 and 2025, Johnson & Johnson diluted shares outstanding declined 22.7%, falling from 3.14B to 2.43B.
2003 marks the peak diluted shares outstanding at 3.14B, with the historical low of 2.43B recorded in 2024.
Johnson & Johnson Shares Outstanding by Year
Johnson & Johnson Shares Outstanding 2025: 2.43B
Johnson & Johnson posted diluted shares outstanding of 2.43B in 2025, edged up 0.0% from 2024.
Johnson & Johnson Shares Outstanding 2024: 2.43B
In 2024, Johnson & Johnson reported diluted shares outstanding of 2.43B, declined 5.1% below 2023. This figure represents the lowest annual value in the available history.
Johnson & Johnson Shares Outstanding 2023: 2.56B
Johnson & Johnson diluted shares outstanding in 2023 was 2.56B, edged down 3.9% below 2022.
Johnson & Johnson Shares Outstanding 2022: 2.66B
2022's diluted shares outstanding for Johnson & Johnson came in at 2.66B, edged down 0.4% below 2021.
Johnson & Johnson Shares Outstanding 2021: 2.67B
Johnson & Johnson diluted shares outstanding in 2021 was 2.67B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by Shares Outstanding
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M | |
| 377.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation